Integrated Analyses of Growth Differentiation Factor-15 Concentration and Cardiometabolic Diseases in Humans
Susanna Lemmelä, Eleanor M. Wigmore, Christian Benner, Aki Havulinna, Rachel M. Y. Ong, Tibor Kempf, Kai C. Wollert, Stefan Blankenberg, Tanja Zeller, James E. Peters, Veikko Salomaa, Maria Fritsch, Ruth March, Aarno Palotie, Mark Daly, Adam S. Butterworth, Mervi Kinnunen, Dirk S. Paul, Athena Matakidou
doi: https://doi.org/10.1101/2021.12.15.21267719
Susanna Lemmelä
1Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Finland
Eleanor M. Wigmore
2Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
Christian Benner
1Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Finland
Aki Havulinna
1Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Finland
3Finnish Institute for Health and Welfare, Helsinki, Finland
Rachel M. Y. Ong
4British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
Tibor Kempf
5Department of Cardiology and Angiology, Hannover Medical School, Germany
Kai C. Wollert
5Department of Cardiology and Angiology, Hannover Medical School, Germany
Stefan Blankenberg
6Clinic for General and Interventional Cardiology, University Heart Centre, Hamburg, Germany
Tanja Zeller
6Clinic for General and Interventional Cardiology, University Heart Centre, Hamburg, Germany
James E. Peters
7Department of Immunology and Inflammation, Faculty of Medicine, Imperial College London, London, UK
8Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, UK
Veikko Salomaa
3Finnish Institute for Health and Welfare, Helsinki, Finland
Maria Fritsch
9Bioscience Renal, Research and Early Development Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
Ruth March
10Precision Medicine, Oncology R&D, AstraZeneca, Cambridge, UK
Aarno Palotie
1Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Finland
11Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
12Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA
Mark Daly
1Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Finland
11Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
12Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA
Adam S. Butterworth
4British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
8Health Data Research UK Cambridge, Wellcome Genome Campus and University of Cambridge, Cambridge, UK
13British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK
14National Institute for Health Research Blood and Transplant Research Unit in Donor Health and Genomics, University of Cambridge, Cambridge, UK
Mervi Kinnunen
1Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Finland
Dirk S. Paul
2Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
4British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
13British Heart Foundation Centre of Research Excellence, University of Cambridge, Cambridge, UK
Athena Matakidou
2Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK
Posted December 16, 2021.
Integrated Analyses of Growth Differentiation Factor-15 Concentration and Cardiometabolic Diseases in Humans
Susanna Lemmelä, Eleanor M. Wigmore, Christian Benner, Aki Havulinna, Rachel M. Y. Ong, Tibor Kempf, Kai C. Wollert, Stefan Blankenberg, Tanja Zeller, James E. Peters, Veikko Salomaa, Maria Fritsch, Ruth March, Aarno Palotie, Mark Daly, Adam S. Butterworth, Mervi Kinnunen, Dirk S. Paul, Athena Matakidou
medRxiv 2021.12.15.21267719; doi: https://doi.org/10.1101/2021.12.15.21267719
Integrated Analyses of Growth Differentiation Factor-15 Concentration and Cardiometabolic Diseases in Humans
Susanna Lemmelä, Eleanor M. Wigmore, Christian Benner, Aki Havulinna, Rachel M. Y. Ong, Tibor Kempf, Kai C. Wollert, Stefan Blankenberg, Tanja Zeller, James E. Peters, Veikko Salomaa, Maria Fritsch, Ruth March, Aarno Palotie, Mark Daly, Adam S. Butterworth, Mervi Kinnunen, Dirk S. Paul, Athena Matakidou
medRxiv 2021.12.15.21267719; doi: https://doi.org/10.1101/2021.12.15.21267719
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)